184 related articles for article (PubMed ID: 22083500)
1. Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins.
Chang SL; Connaghan KP
J Neuroimmune Pharmacol; 2012 Jun; 7(2):332-40. PubMed ID: 22083500
[TBL] [Abstract][Full Text] [Related]
2. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
3. Partial characterization and tissue distribution of the feline mu opiate receptor.
Billet O; Billaud JN; Phillips TR
Drug Alcohol Depend; 2001 Apr; 62(2):125-9. PubMed ID: 11245968
[TBL] [Abstract][Full Text] [Related]
4. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF
Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704
[TBL] [Abstract][Full Text] [Related]
5. Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model.
Chang SL; Beltran JA; Swarup S
J Virol; 2007 Aug; 81(16):8406-11. PubMed ID: 17553897
[TBL] [Abstract][Full Text] [Related]
6. Modulation of OPRM1 Alternative Splicing by Morphine and HIV-1 Nef.
Donadoni M; Huang W; Yarandi SS; Burdo TH; Chang SL; Sariyer IK
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):277-288. PubMed ID: 34420144
[TBL] [Abstract][Full Text] [Related]
7. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
[TBL] [Abstract][Full Text] [Related]
8. The proteins interacting with C-terminal of μ receptor are identified by bacterial two-hybrid system from brain cDNA library in morphine-dependent rats.
Zhou P; Jiang J; Dong Z; Yan H; You Z; Su R; Gong Z
Life Sci; 2015 Dec; 143():156-67. PubMed ID: 26522050
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
11. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
Gavériaux-Ruff C; Matthes HW; Peluso J; Kieffer BL
Proc Natl Acad Sci U S A; 1998 May; 95(11):6326-30. PubMed ID: 9600964
[TBL] [Abstract][Full Text] [Related]
12. Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization.
Dang VC; Chieng B; Azriel Y; Christie MJ
J Neurosci; 2011 May; 31(19):7122-30. PubMed ID: 21562274
[TBL] [Abstract][Full Text] [Related]
13. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
[TBL] [Abstract][Full Text] [Related]
14. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
15. How does morphine work?
Iversen LL
Nature; 1996 Oct; 383(6603):759-60. PubMed ID: 8892994
[No Abstract] [Full Text] [Related]
16. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
Wang D; Raehal KM; Bilsky EJ; Sadée W
J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
[TBL] [Abstract][Full Text] [Related]
17. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
[TBL] [Abstract][Full Text] [Related]
18. Effects of ATPM-ET, a novel κ agonist with partial μ activity, on physical dependence and behavior sensitization in mice.
SUN JF; WANG YH; LI FY; LU G; TAO YM; CHENG Y; CHEN J; XU XJ; CHI ZQ; NEUMEYER JL; ZHANG A; LIU JG
Acta Pharmacol Sin; 2010 Dec; 31(12):1547-52. PubMed ID: 21102484
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.
Dever SM; Xu R; Fitting S; Knapp PE; Hauser KF
J Neurovirol; 2012 Jun; 18(3):181-90. PubMed ID: 22528479
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of morphine- and cocaine-induced nNOS immunoreactivity in the dentate gyrus of hippocampus of mice lacking mu-opioid receptors.
Yoo JH; Cho JH; Lee SY; Lee S; Loh HH; Ho IK; Jang CG
Neurosci Lett; 2006 Mar; 395(2):98-102. PubMed ID: 16300892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
